Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude+Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Charles River Laboratories International, Inc. Common Stock
(NY:
CRL
)
149.94
-2.50 (-1.64%)
Streaming Delayed Price
Updated: 10:01 AM EDT, May 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Charles River Laboratories International, Inc. Common Stock
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Charles River Laboratories to Present at Baird and Morgan Stanley Conferences
September 08, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Cure AP-4 Announce Gene Therapy Manufacturing Collaboration
September 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Expert Ratings for Charles River
↗
August 25, 2022
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:
Via
Benzinga
Charles River Laboratories Expands Contract Vivarium Space on West Coast
August 23, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Recap: Charles River Q2 Earnings
↗
August 03, 2022
Charles River (NYSE:CRL) reported its Q2 earnings results on Wednesday, August 3, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 25, 2022
↗
August 25, 2022
Upgrades
Via
Benzinga
NexImmune Price Target Cut By 75%, Plus Wells Fargo Lowers PT Price Target On These Stocks
↗
August 16, 2022
Raymond James cut the price target for NexImmune, Inc. (NASDAQ: NEXI) from $12 to $3. NexImmune shares rose 2.4% to $1.29 in pre-market trading.
Via
Benzinga
Analyst Ratings for Charles River
↗
May 24, 2022
Within the last quarter, Charles River (NYSE:CRL) has observed the following analyst ratings:
Via
Benzinga
Charles River: Q1 Earnings Insights
↗
May 04, 2022
Charles River (NYSE:CRL) reported its Q1 earnings results on Wednesday, May 4, 2022 at 07:00 AM. Here's what investors need to know about the announcement.
Via
Benzinga
Charles River Laboratories is First CDMO in North America to Receive EMA Approval to Commercially Produce an Allogeneic Cell Therapy Drug Product
August 09, 2022
From
Charles River Laboratories, International Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For August 4, 2022
↗
August 04, 2022
Upgrades
Via
Benzinga
AMD, SolarEdge Technologies And Some Other Big Stocks Moving Lower On Wednesday
↗
August 03, 2022
Rocky Brands, Inc. (NASDAQ: RCKY) dipped 21.6% to $26.62 after the company reported worse-than-expected Q2 EPS results.
Via
Benzinga
Charles River Laboratories Announces Second-Quarter 2022 Results
August 03, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
'I'm Going To Have To Say Avoid It': Jim Cramer Urges Waiting Before Buying This Tech Stock
↗
August 02, 2022
On CNBC’s "Mad Money Lightning Round," Jim Cramer recommended buying Charles River Laboratories International Inc (NYSE: CRL).
Via
Benzinga
Where Charles River Stands With Analysts
↗
July 14, 2022
Over the past 3 months, 5 analysts have published their opinion on Charles River (NYSE:CRL) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
Charles River Laboratories Schedules Second-Quarter 2022 Earnings Release and Conference Call
July 11, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
June 28, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
June 23, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
June 13, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
June 06, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
↗
May 24, 2022
Upgrades
Via
Benzinga
Charles River Laboratories Announces First-Quarter 2022 Results
May 04, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
Preview: Charles River's Earnings
↗
May 03, 2022
Charles River (NYSE:CRL) is set to give its latest quarterly earnings report on Wednesday, 2022-05-04. Here's what investors need to know before the announcement. Analysts estimate that Charles River...
Via
Benzinga
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
April 27, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
3 Top S&P 500 Stock Market Gainers Today: Coronavirus Vaccine Maker Moderna Jumps
↗
April 25, 2022
Moderna led big-cap winners Monday. Oil services giants were losers.
Via
Investor's Business Daily
Wells Fargo Maintains Overweight Rating for Charles River: Here's What You Need To Know
↗
April 25, 2022
Wells Fargo has decided to maintain its Overweight rating of Charles River (NYSE:CRL) and lower its price target from $390.00 to $325.00. Shares of Charles River are trading down 7.96% over the last 24...
Via
Benzinga
What 6 Analyst Ratings Have To Say About Charles River
↗
April 25, 2022
Analysts have provided the following ratings for Charles River (NYSE:CRL) within the last quarter:
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
↗
April 25, 2022
Via
Benzinga
10 Biggest Price Target Changes For Monday
↗
April 25, 2022
Keybanc cut Salesforce, Inc. (NYSE: CRM) price target from $281 to $223. Salesforce shares fell 1.1% to $169.60 in pre-market trading.
Via
Benzinga
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
April 13, 2022
From
Charles River Laboratories International, Inc.
Via
Business Wire
< Previous
1
2
...
15
16
17
18
19
20
21
22
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
